Real-world efficacy of nivolumab plus ipilimumab combination therapy versus nivolumab monotherapy for Stage IV melanoma patients in Asia

被引：1
|
作者：
Maeda, Takuya [1 ]
Hiura, Azusa [1 ]
Uehara, Jiro [1 ]
Toyoshima, Rino [1 ]
Nakagawa, Tomoe [1 ]
Yoshino, Koji [1 ]
机构：
[1] Tokyo Metropolitan Canc & Infect Dis Ctr Komagome, Dept Dermatol Oncol, Tokyo, Japan
来源：
EUROPEAN JOURNAL OF DERMATOLOGY | 2021年 / 31卷 / 05期
关键词：
JAPANESE PATIENTS; SAFETY;
D O I：
10.1684/ejd.2021.4139
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：662 / 664
页数：3
相关论文
共 50 条
  • [31] Efficacy and toxicity of Ipilimumab-Nivolumab combination therapy in elderly metastatic melanoma patients
    Stoff, Ronen
    Grynberg, Shirly
    Asher, Nethanel
    Laks, Shachar
    Steinberg, Yael
    Schachter, Jacob
    Shapira-Frommer, Ronnie
    Ben-Betzalel, Guy
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [32] Pathology of durable stable disease in melanoma patients treated with ipilimumab, nivolumab, or ipilimumab, and nivolumab combination therapy.
    Buchbinder, Elizabeth Iannotti
    Pfaff, Kathleen L.
    Manos, Michael P.
    Ouyang, Olivia
    Ott, Patrick Alexander
    Rodig, Scott J.
    Hodi, F. Stephen
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO
    Gutzmer, R.
    Eigentler, T.
    Mohr, P.
    Weichenthal, M.
    Duecker, P.
    Gebhardt, C.
    Goeppner, D.
    Haferkamp, S.
    Kaehler, K.
    Meier, F.
    Pfoehler, C.
    Satzger, I.
    Sickmann, T.
    Sindrilaru, A.
    Terheyden, P.
    Ugurel, S.
    Ulrich, J.
    Utikal, J.
    Weishaupt, C.
    Schadendorf, D.
    ANNALS OF ONCOLOGY, 2020, 31 : S746 - S747
  • [34] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Blank, Christian U.
    Rozeman, Elisa A.
    Fanchi, Lorenzo F.
    Sikorska, Karolina
    van de Wiel, Bart
    Kvistborg, Pia
    Krijgsman, Oscar
    van den Braber, Marlous
    Philips, Daisy
    Broeks, Annegien
    van Thienen, Johannes, V
    Mallo, Henk A.
    Adriaansz, Sandra
    ter Meulens, Sylvia
    Pronk, Loes M.
    Grijpink-Ongering, Lindsay G.
    Bruining, Annemarie
    Gittelman, Rachel M.
    Warren, Sarah
    van Tinteren, Harm
    Peeper, Daniel S.
    Haanen, John B. A. G.
    van Akkooi, Alexander C. J.
    Schumacher, Ton N.
    NATURE MEDICINE, 2018, 24 (11) : 1655 - +
  • [35] Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma
    Christian U. Blank
    Elisa A. Rozeman
    Lorenzo F. Fanchi
    Karolina Sikorska
    Bart van de Wiel
    Pia Kvistborg
    Oscar Krijgsman
    Marlous van den Braber
    Daisy Philips
    Annegien Broeks
    Johannes V. van Thienen
    Henk A. Mallo
    Sandra Adriaansz
    Sylvia ter Meulen
    Loes M. Pronk
    Lindsay G. Grijpink-Ongering
    Annemarie Bruining
    Rachel M. Gittelman
    Sarah Warren
    Harm van Tinteren
    Daniel S. Peeper
    John B. A. G. Haanen
    Alexander C. J. van Akkooi
    Ton N. Schumacher
    Nature Medicine, 2018, 24 : 1655 - 1661
  • [36] Efficacy and safety of nivolumab plus ipilimumab versus nivolumab alone in patients with advanced melanoma: a systematic review and meta-analysis
    Cui, Shuting
    Sun, Xiaozhe
    Gao, Junxi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2024, 24 (05) : 283 - 291
  • [37] Real-world comparison of outcomes in the first line treatment of metastatic melanoma according to BRAF mutation status: Nivolumab and ipilimumab therapy vs. nivolumab monotherapy.
    Klein-Brill, Avital
    Amar-Farkash, Shlomit
    Fisch, Michael Jordan
    Aran, Dvir
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [38] Postmarketing surveillance of nivolumab plus ipilimumab combination therapy in Japanese patients with unresectable malignant melanoma
    Yamazaki, Naoya
    Kiyohara, Yoshio
    Uhara, Hisashi
    Tsuchida, Tetsuya
    Yoshida, Ai
    Yamada, Takako
    Komoto, Akira
    JOURNAL OF DERMATOLOGY, 2023, 50 (09): : 1108 - 1120
  • [39] Partial Remission of advanced Melanoma by Combination Therapy with Nivolumab and Trametinib after Treatment Failure with Ipilimumab plus Nivolumab
    Zaremba, A.
    Chorti, E.
    Jockenhoefer, F.
    Albrecht, M.
    Placke, J. M.
    Knispel, S.
    Schadendorf, D.
    Hadaschik, E.
    Roesch, A.
    Ugurel, S.
    Zimmer, L.
    Livingstone, E.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2018, 16 : 38 - 38
  • [40] Efficacy and safety of nivolumab in metastatic melanoma: real-world practice
    Bocquet-Tremoureux, Solene
    Scharbarg, Emeric
    Nguyen, Jean-Michel
    Varey, Emilie
    Quereux, Gaelle
    Saint-Jean, Melanie
    Peuvrel, Lucie
    Khammari, Amir
    Dreno, Brigitte
    EUROPEAN JOURNAL OF DERMATOLOGY, 2019, 29 (03) : 315 - 321
12345